Literature DB >> 4683130

Urinary catecholamine metabolites during behavioral changes in a patient with manic-depressive cycles.

F D Jones, J W Maas, H Dekirmenjian, J A Fawcett.   

Abstract

3-Methoxy-4-hydroxyphenylglycol and normetanephrine were analyzed in daily urine specimens of a patient with manic-depressive cycles who was studied longitudinally. The quantities of these catecholamine metabolites excreted into urine were decreased during periods of depression as compared with periods of mania. Urinary excretion of 3-methoxy-4-hydroxyphenylglycol varied cyclically with a period length of approximately 20 days. Changes in this metabolite, and perhaps in normetanephrine, preceded the affective and behavioral shifts.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4683130     DOI： 10.1126/science.179.4070.300

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  8 in total

1.  The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

Authors:  P Riederer; W Birkmayer; E Neumayer; L Ambrozi; W Linauer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

2.  The effect of clonidine withdrawal on total 3-methoxy-4-hydroxyphenylglycol in the rat brain.

Authors:  S W Tang; D M Helmeste; H C Stancer
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

Review 3.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

4.  MHPG excretion in endogenous depression: relationship to clinical state and the effects of ECT.

Authors:  M H Joseph; D Risby; T J Crow; J F Deakin; E C Johnstone; P Lawler
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Fluvoxamine-a new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients.

Authors:  B Saletu; M Schjerve; J Grünberger; H Schanda; O H Arnold
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

6.  Plasma renin activity in primary and secondary depression.

Authors:  A C Altamura; A Morganti; E Smeraldi; A Zanchetti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

7.  Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.

Authors:  R Hoeldtke; M Rogawski; R J Wurtman
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

Review 8.  Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

Authors:  W Z Potter
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.